ICMR formalises MoAs with multiple sponsors under phase one clinical trials network
ICMR formalizes MoAs with sponsors for phase 1 clinical trials of four promising molecules, including research on multiple myeloma, Zika vaccine, seasonal influenza vaccine, and CAR-T cell therapy for chronic lymphocytic leukaemia, aiming to establish India as a leader in pharmaceutical agent development.
Reference News
ICMR formalises MoAs with multiple sponsors under phase one clinical trials network
ICMR formalizes MoAs with sponsors for phase 1 clinical trials of four promising molecules, including research on multiple myeloma, Zika vaccine, seasonal influenza vaccine, and CAR-T cell therapy for chronic lymphocytic leukaemia, aiming to establish India as a leader in pharmaceutical agent development.